FDA NDC Directory · JSON-LD · Markdown

Opill

NDC 0113-8101 · HUMAN OTC DRUG · TABLET

Generic namenorgestrel
Labeler / ManufacturerL. Perrigo Company
Marketing categoryNew Drug Application (innovator) · App NDA017031
Dosage form / routeTABLET · ORAL
Active ingredientsNORGESTREL (.075 mg/1)
Marketing started20240304
Package count4

External sources

Source: openFDA. Public-domain (CC0).